Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Gao, Y, O'Hely, M, Quinn, TP, Ponsonby, A-L, Harrison, LC, Frøkiær, H, Tang, MLK, Brix, S, Kristiansen, K, Burgner, D, et al.
Maternal gut microbiota during pregnancy and the composition of immune cells in infancy..
Front Immunol
13:
986340
2022
view publication
Hoggart, C, Shimizu, C, Galassini, R, Wright, VJ, Shailes, H, Bellos, E, Herberg, JA, Pollard, AJ, O'Connor, D, Choi, SW, et al.
Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease..
Eur J Hum Genet
29(12)
:
1734 -1744
2021
view publication
Du Berry, C, Saunders, T, McMinn, A, Tosif, S, Shanthikumar, S, Vandeleur, M, Harrison, J, Burgner, D, Ranganathan, S, Crawford, N, et al.
Is cardiorespiratory disease associated with increased susceptibility of SARS-CoV-2 in children?.
Pediatr Pulmonol
56(12)
:
3664 -3668
2021
view publication
Todd, IMF, Miller, JE, Rowe, SL, Burgner, DP, Sullivan, SG.
Changes in infection-related hospitalizations in children following pandemic restrictions: an interrupted time-series analysis of total population data..
Int J Epidemiol
50(5)
:
1435 -1443
2021
view publication
Wurzel, D, McMinn, A, Hoq, M, Blyth, CC, Burgner, D, Tosif, S, Buttery, J, Carr, J, Clark, JE, Cheng, AC, et al.
Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study..
BMJ Open
11(11)
:
e054510
2021
view publication